Results 1 to 10 of about 604,420 (291)

Addiction [PDF]

open access: yesBritish Medical Bulletin, 2003
Alcohol and psycho-active substance misuse has far-reaching social, psychological and physical consequences. Advances in neuroimaging technology have allowed neurobiological theories of addiction to become better characterized. We describe the neurobiology of dependence, withdrawal, abstinence and craving states in alcohol, stimulant and opiate misuse.
Lingford-Hughes, A   +5 more
openaire   +5 more sources

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)

open access: yesBMC Nutrition, 2022
Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on various indicators and possibly
Lars T. Fadnes   +10 more
doaj   +1 more source

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)

open access: yesTrials, 2022
Background About 85% of patients receiving opioid agonist therapy (OAT) for opioid dependence are smoking tobacco. Although smoke-related pulmonary diseases are significant contributors to morbidity and mortality, few smoking cessation interventions are ...
Karl Trygve Druckrey-Fiskaaen   +7 more
doaj   +1 more source

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway

open access: yesScientific Reports, 2022
Chronic and harmful substance use is associated with a cluster of harms to health, including micronutrient deficiencies. Maintaining adequate levels of vitamin D is important for musculoskeletal and other aspects of health.
Mitra Bemanian   +6 more
doaj   +1 more source

Addictions

open access: yesRevue Médicale Suisse, 2019
New drugs available in a click, plethora of games, new regulations on cannabis, addiction medicine has a lot to do ! In 2018, Switzerland recognized a training certificate in addiction medicine, pathological gambling entered into ICD-11 and vaping, first considered with suspicion, found a place in the pharmacopoeia of the fight against tobacco.
Daeppen, Jean-Bernard   +8 more
openaire   +6 more sources

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

open access: yesBMC Psychiatry, 2020
Background Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD).
Muhammad Ishrat Husain   +14 more
doaj   +1 more source

Equine-assisted services for individuals with substance use disorders: a scoping review

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
The implementation of equine-assisted services (EAS) during treatment for psychological disorders has been frequently documented; however, little is known about the effect of EAS on outcomes for populations with substance use disorder (SUD).
Liam Diaz   +6 more
doaj   +1 more source

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

open access: yesTranslational Psychiatry, 2021
Patients with schizophrenia have exceedingly high rates of metabolic comorbidity including type 2 diabetes and lose 15–20 years of life due to cardiovascular diseases, with early accrual of cardiometabolic disease.
Sri Mahavir Agarwal   +15 more
doaj   +1 more source

Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2023
Background Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-economic consequences of such use, but ...
Dvora Shmulewitz   +3 more
doaj   +1 more source

Addictions

open access: yesRevue Médicale Suisse, 2017
In 2016, the actuality for addictions in this edition addresses four points. Social neurosciences of addiction are of great importance regarding the vulnerabilities for addiction and for the recovery. Deep brain stimulation is emerging in the therapeutic panel coming from the clinical neurosciences for the addictions.
Besson, Jacques   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy